Brief: Immucell Says Sees 12% Increase In Total Product Sales To About $15.3 Mln During Year Ended December 31, 2020
07/01/2021 19:34
Jan 7 (Reuters) - ImmuCell Corp ICCC.O :
* EXPECT TO REPORT A 12% INCREASE IN TOTAL PRODUCT SALES TO
APPROXIMATELY $15.3 MILLION DURING YEAR ENDED DECEMBER 31, 2020
Source text for Eikon: urn:newsml:reuters.com:*:nNDL9FP794
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year